Researchers are investigating a range of nanomaterials that respond to cancer-specific stimuli for delivering imaging compounds and treatments specifically to cancer cells, such as protease-sensitive nanomaterials. (Copyright: ACS Ind. Eng. Chem. Res. 2017, 56, 20, 5761-5777)